When you are making a point that the country that put humans on the moon also has the capacity to cure cancers, venue and timing matter. On Sept. 12, President Joe Biden chose John F. Kennedy Presidential Library and Museum—and the 60th anniversary of Kennedy’s 1962 moonshot speech—to announce his plan’s latest iteration.
President Joe Biden has announced his intent to appoint Monica Bertagnolli as the 16th director of the National Cancer Institute—and the first woman and first chair of a clinical trials cooperative group to be named to the role.
Monica M. Bertagnolli, a professor of surgery at Harvard Medical School, stands poised to become the first woman and the first chair of a clinical trials cooperative group to be named director of the National Cancer Institute.
In a move that appears to prioritize biomedical engineering over cancer research, President Joe Biden’s proposal for fiscal year 2023 cuts NCI funding by $199 million, a 2.9% percent cut from the current year’s level.
Changes at Mission Control notwithstanding, the new Cancer Moonshot is ready for liftoff, says Danielle Carnival, coordinator of the White House cancer initiative.
On Feb. 1, as President Joe Biden was preparing to fire up the Cancer Moonshot, Eric Lander was the scientist in charge of mission control.
The White House has announced an expansion of the Cancer Moonshot’s mission beyond its initial focus on accelerating research and data sharing in oncology—with promises of renewed funding for an array of ambitious presidential initiatives.
President Joe Biden is requesting $52 billion in FY2022 for NIH—$9 billion above the enacted FY21 level—of which $6.5 billion is slated for the proposed Advanced Research Projects Agency for Health.
In an expression of support for increasing funding for cancer research and prevention, the Bidens earlier this week endorsed the National Cancer Research Month.
